Literature DB >> 14685026

Expression of apxIA of Actinobacillus pleuropneumoniae in Saccharomyces cerevisiae.

Sung Jae Shin1, Jong Lye Bae, Young Wook Cho, Moon Sik Yang, Dae Hyuk Kim, Yong Suk Jang, Han Sang Yoo.   

Abstract

Actinobacillus pleuropneumoniae is an important primary pathogen in pigs, in which it causes a highly contagious pleuropneumoniae. In our previous study, apxIA gene amplified from A. pleuropneumoniae Korean isolate by PCR with primer designed based on the N- and C-terminal of the toxin was cloned in TA cloning vector and sequenced. The nucleotide sequences of apxIA gene was reported to GenBank with the accession numbers of AF363361. Identity of the Apx IA from the cloned gene in E. coli was proved by SDS-PAGE and Western blot. Yeast has been demonstrated to be an excellent host for the expression of recombinant proteins with uses in diagnostics, therapeutics and vaccine productions. Therefore, to use the yeast as a delivery system in new oral subunit vaccine, apxIA gene was subcloned into Saccharomyces cerevisiae, and identified the expression of Apx IA protein. First, apxIA gene was amplified by PCR with the primers containing BamHI and SalI site at each end. Second, the DNA digested with BamHI and SalI was ligated into YEpGPD-TER vector, and transformed into S. cerevisiae 2805. Third, after identification of the correctly oriented clone, the 120-kDa of Apx IA protein expressed in S. cerevisiae 2805 was identified by SDS-PAGE and Western blot.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14685026

Source DB:  PubMed          Journal:  J Vet Sci        ISSN: 1229-845X            Impact factor:   1.672


  3 in total

1.  Polymorphism analysis of the apxIA gene of Actinobacillus pleuropneumoniae serovar 5 isolated in swine herds from Brazil.

Authors:  Lucas Fernando Dos Santos; Richard Costa Polveiro; Thalita Scatamburlo Moreira; Pedro Marcus Pereira Vidigal; Yung-Fu Chang; Maria Aparecida Scatamburlo Moreira
Journal:  PLoS One       Date:  2018-12-18       Impact factor: 3.240

2.  Enhancement of protective immune responses by oral vaccination with Saccharomyces cerevisiae expressing recombinant Actinobacillus pleuropneumoniae ApxIA or ApxIIA in mice.

Authors:  Sung Jae Shin; Seung Won Shin; Mi Lan Kang; Deog Yong Lee; Moon-Sik Yang; Yong-Suk Jang; Han Sang Yoo
Journal:  J Vet Sci       Date:  2007-12       Impact factor: 1.672

3.  Cytoplasmic glycoengineering of Apx toxin fragments in the development of Actinobacillus pleuropneumoniae glycoconjugate vaccines.

Authors:  Ian J Passmore; Anna Andrejeva; Brendan W Wren; Jon Cuccui
Journal:  BMC Vet Res       Date:  2019-01-03       Impact factor: 2.741

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.